首页> 美国卫生研究院文献>British Journal of Cancer >Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma
【2h】

Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma

机译:18F-FDG-PET在预测口腔鳞状细胞癌中由肿瘤PD-L1和CD8 +肿瘤浸润淋巴细胞定义的肿瘤免疫状态的诊断价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

F-FDG-uptake was compared between the cold tumour group and the others group. In the cold tumour group, median F-FDG-uptake was 10.98 while it was 6.25 in the others group. shows independent samples median test (  = 0.024). ROC analysis showed that the optimal cut-off value for a cold tumour was 11.4 (AUC = 0.65,  = 0.04, sensitivity = 50%, specificity = 91%; Patients with F-FDG-uptake above 11.4 for cold tumours were defined as having high F-FDG-uptake.
机译:比较冷肿瘤组和其他组的F-FDG摄取。在冷肿瘤组中,F-FDG摄取中位数为10.98,而在其他组中为6.25。显示独立样本的中位数测试(= 0.024)。 ROC分析显示,冷肿瘤的最佳临界值为11.4(AUC = 0.65,= 0.04,敏感性= 50%,特异性= 91%; F-FDG摄取高于11.4的冷肿瘤患者定义为高F-FDG摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号